Zogenix

$22.23
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (+0.68%) As of 1:26 PM EST today

Why Robinhood?

You can buy or sell Zogenix and other stocks, options, and ETFs commission-free!

About ZGNX

Zogenix, Inc. Common Stock, also called Zogenix, is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. The listed name for ZGNX is Zogenix, Inc. Common Stock.

CEO

Stephen James Farr

Employees

141

Headquarters

Emeryville, California

Founded

2006

Market Cap

1.23B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

728.56K

High Today

$22.80

Low Today

$22.13

Open Price

$22.16

Volume

328.47K

52 Week High

$57.22

52 Week Low

$16.65

Collections

Analyst Ratings

77%

of 13 ratings

Buy

77%

Hold

23%

Sell

ZGNX Earnings

-$1.18

-$0.79

-$0.39

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 1, After Hours